Supplementary Data from The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer
McCuaig S., Barras D., Mann EH., Friedrich M., Bullers SJ., Janney A., Garner LC., Domingo E., Koelzer VH., Delorenzi M., Tejpar S., Maughan TS., West NR., Powrie F.